| Literature DB >> 31641673 |
Kevin M Klifto1,2, Caresse F Gurno3, Michael J Grzelak1, Stella M Seal4, Mohammed Asif1,2, C Scott Hultman1,2, Julie A Caffrey1,2.
Abstract
BACKGROUND: Cutaneous manifestations of purpura fulminans (PF) present many challenges for clinicians and surgeons. In a state of septic shock complicated by limb ischemia, surgical interventions are necessary to control the pathological cascade and improve patient outcomes. The objective of this article was to report etiologies and surgical outcomes associated with cutaneous manifestations in adults.Entities:
Keywords: Amputation; Burn units; Neisseria; Purpura fulminans; Reconstructive surgical procedures; Septic; Shock; Surgeons; Treatment outcome
Year: 2019 PMID: 31641673 PMCID: PMC6798408 DOI: 10.1186/s41038-019-0168-x
Source DB: PubMed Journal: Burns Trauma ISSN: 2321-3868
Fig. 1Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) flow chart summarizes the results of the screening process and final article selections
Fig. 2Number of purpura fulminans studies published per decade from 1968 to 2019
Summary of findings for patient demographics from qualitative and quantitative synthesis
| Total number of patients | Sex | Age, years | Etiology | Infectious organism |
|---|---|---|---|---|
| 190 | • Males = 94 • Females = 89 • Unidentified = 7 | 40 (26–58) | • Infectious organism = 171 • Unknown = 9 • Not infectious = 6 • No organism found = 4 | • • • • • • • • • • • • • • • • • • Leptospirosis = 1 • • Cytomegalovirus = 1 • Varicella = 1 • West Nile Virus = 1 |
IQR interquartile range
Summary of findings for patient outcomes from qualitative and quantitative synthesis
| Total number of patients | Debridement | Time to debridement, days | Amputations | Amputations (bones removed/transected) | Time to amputation, days | Reconstruction (grafts) | Reconstruction (flaps) | Time to reconstruction, days | Hospital LOS, days | Complications | Mortality | Time to mortality, days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 190 | 71/190 cases | 12.5 (1.8–20.3) | •154/190 cases •Limbs involved = 4 (4–4) •BKA = 64 •AKA = 30 •Below-the-elbow = 28 •Above-the-elbow = 3 | 56 (9–84) | 18 (14–28) | •Total grafts = 33 •ADM = 3 •STSG = 13 •FTSG = 1 •Undifferentiated allografts = 5 •Undifferentiated autografts = 7 •Unknown = 4 | •Total flaps = 28 •Latissimus dorsi = 7 •Orbicularis oris = 4 •Serratus anterior = 2 •Posterolateral thigh = 1 •Free ALT = 1 •Free medial gastrocnemius = 1 •Gracilis = 1 •Internal island saphenous = 1 •Free forearm = 1 •Lateral arm = 1 •Forehead = 1 | 39 (23–56) | 57 (43.3–87.8) | •28/190 cases •Secondary infection = 20 •DVT/PE = 5 •Scarring = 5 •Wound contracture = 3 •Pressure ulcer = 1 •Wound breakdown = 1 •Alar stenosis = 1 •Facial deformity = 1 •Heterotopic ossification = 1 | 34/190 cases | 36 (26.3–72.8) |
IQR interquartile range, BKA below-the-knee amputation, AKA above-the-knee amputation, ADM acellular dermal matrix, STSG split-thickness skin graft, FTSG full-thickness skin graft, ALT anterolateral thigh, LOS length of stay, DVT deep vein thrombosis, PE pulmonary embolism
Comparisons between the numbers of the bones removed or transected from patients during amputation with a specific organism using linear regression from quantitative data synthesis
| Organisms | Number of the bones removed or transected, Median (IQR) | Unstandardized beta coefficient (bones removed or transected) | 95%CI | |
|---|---|---|---|---|
|
| 28 (28–28) | 1.152 | [− 83.7–86] | 0.978 |
|
| 54 (11–63) | 21.425 | [− 16.5–59.3] | 0.264 |
|
| 84 (84–84) | 60.980 | [− 23.8–145.8] | 0.156 |
|
| 0 (0–0) | − 28.762 | [− 113.6–56.1] | 0.501 |
| Coagulase-negative | 114 (114–114) | 93.030 | [8.2–177.9] |
|
| Cytomegalovirus | 0 (0–0) | − 28.762 | [− 113.6–56.1] | 0.501 |
|
| 56 (25–56) | 32.361 | [− 12.5–77.2] | 0.115 |
|
| 56 (56–56) | 31.066 | [− 53.8–115.9] | 0.468 |
|
| 93 (79–106) | 70.088 | [7.2–133] |
|
|
| 0 (0–0) | − 12.728 | [− 75.6–50.2] | 0.688 |
| Leptospirosis | 3 (3–3) | − 25.557 | [− 110.4–59.3] | 0.550 |
|
| 56 (18–61) | 20.207 | [− 10.4–50.8] | 0.192 |
| No organism | 60 (30–87) | 32.136 | [− 16.2–80.5] | 0.190 |
|
| 59 (59–59) | 34.271 | [− 50.6–119.1] | 0.423 |
|
| 71 (50–93) | 47.104 | [− 15.8–110] | 0.140 |
|
| 0 (0–0) | − 28.762 | [− 113.6–56.1] | 0.501 |
|
| 75 (42–99) | 41.780 | [− 6.6–90.1] | 0.089 |
|
| 85 (41–95) | 44.603 | [13.3–75.9] |
|
|
| 90 (45–105) | 45.692 | [− 7.9–99.3] | 0.094 |
|
| 0 (0–0) | − 28.762 | [− 113.6–56.1] | 0.501 |
| Unknown | 0 (0–84) | 14.600 | [− 27.8–57] | 0.495 |
| Varicella | 14 (14–14) | − 13.805 | [− 98.6–71] | 0.747 |
| West Nile Virus | 114 (114–114) | 93.030 | [8.2–177.9] |
|
IQR interquartile range, CI confidence interval